• NYC bill calls for info sharing on off-label uses for weight loss drugs

    New York City Councilwoman Julie Menin introduced a bill March 7 that would require the city's Commissioner of Health and Mental Hygiene to create and distribute materials about the possible negative health effects from prescribing and using prescription drugs for their off-label use for weight loss. 
  • Novo Nordisk trial-stage weight loss pill outperforming Wegovy

    After finding success in the emerging sector of semaglutide drugs, Novo Nordisk's latest work toward development of it in pill form has shown results that are even better than Wegovy when it comes to shedding weight.
  • Ozempic patients seek plastic surgery after weight loss

    Physicians are reportedly seeing an increasing number of patients who have used anti-obesity drugs like Ozempic and Wegovy request procedures to remove sagging, excess skin via plastic surgery, KDVR reported Feb. 23.

Featured Whitepapers

Featured Webinars

>